Cover image of Brian Rini

Brian Rini Podcasts

Read more

7 of The Best Podcast Episodes for Brian Rini. A collection of podcasts episodes with or about Brian Rini, often where they are interviewed.

Read more

7 of The Best Podcast Episodes for Brian Rini. A collection of podcasts episodes with or about Brian Rini, often where they are interviewed.

Updated daily with the latest episodes

Episode artwork

Studying cancer patients with COVID-19: Dr. Brian Rini describes the NCCAPS and CCC19 studies and reviews the latest findings

Play
Read more

How do patients fare when they have cancer and COVID-19? Researchers developed the COVID-19 and Cancer Consortium (CCC19) and the National Cancer Institute COVID-19 in Cancer Patients Study (NCCAPS) to gain some insight.

In this episode, Brian Rini, MD, a professor of medicine at Vanderbilt University Medical Center, Nashville, Tenn., and host of The Uromigos podcast, explains what CCC19 and NCCAPS are. He also discusses findings from CCC19 that were presented at the European Society of Medical Oncology Virtual Congress 2020.

NCCAPS (NCT04387656)

  • NCCAPS is a natural history study of COVID-19 in patients with active cancer.
  • It is a prospective study, funded by the National Cancer Institute, that is open at more than 500 centers.
  • The study is open to U.S. adults who are receiving active cancer treatment and either have COVID-19 or are awaiting a SARS-CoV-2 test result.
  • Researchers collect blood samples and other data from patients enrolled.
    • Blood is collected at baseline and at regular intervals incorporated into patients’ normal oncology follow-up.
    • The samples will be used to assess things like genomics, cytokine abnormalities, and coagulation parameters.
  • No data from NCCAPS have been released to date, but more than 100 patients have been enrolled.
  • For more information, visit the NCCAPS webpage: https://bit.ly/3ck8nBb.

CCC19 (NCT04354701)

  • CCC19 is a retrospective database that includes information on patients with active cancer or a history of cancer who have been diagnosed with COVID-19, with or without a confirmatory test.
  • Health care providers or their proxies from the United States, European Union, Argentina, Canada, Mexico, and United Kingdom can report cases through the CCC19 website.
  • All data are deidentified.
  • More than 100 institutions are now part of CCC19.
  • Data from CCC19 were presented in two abstracts at ESMO 2020:
  • The data from LBA72, which includes nearly 4,000 patients, suggest cancer-specific factors are associated with a greater risk of 30-day all-cause mortality, including:
    • Progressive cancer (adjusted odds ratio, 2.9).
    • Hematologic malignancy (aOR, 1.7).
    • Receiving cancer therapy within the past 3 months (aOR, 1.2).
  • It still isn’t clear if certain cancer treatments increase the risk of mortality, Dr. Rini said, but researchers are investigating that.
  • For more information on CCC19, visit https://ccc19.org/.

Disclosures:

Dr. Rini and Dr. Henry have no relevant conflicts of interest.

*  *  *

For more MDedge Podcasts, go to mdedge.com/podcasts

Email the show: podcasts@mdedge.com

Interact with us on Twitter: @MDedgehemonc

David Henry on Twitter: @davidhenrymd

Sep 24 2020 · 23mins
Episode artwork

#005_ASCO GU 2019 | Câncer Renal (Estudo TIVO-3) - Dr. Brian Rini

Play
Read more
Dr. Brian Rini, professor da Cleveland Clinic Lerner College of Medicine, comenta as novidades em câncer renal apresentadas na ASCO GU 2019 e destaca o estudo de fase III TIVO-3, que comparou tivozanib com sorafenibe em pacientes com carcinoma de células renais avançado (CCR) refratário.
May 29 2019 · 1min
Episode artwork

#004_ASCO GU 2019 | Estudo KEYNOTE-426 -Dr. Brian Rini

Play
Read more
Dr. Brian Rini, professor da Cleveland Clinic Lerner College of Medicine, comenta o estudo KEYNOTE-426.
May 29 2019 · 1min
Episode artwork

2016 ASCO Annual Meeting Research Round Up – Bladder Cancer and Kidney Cancer, with Brian Rini, MD

Play
Read more

In today’s podcast, Cancer.Net Associate Editor Dr. Brian Rini discusses some of the new research on kidney and bladder cancer presented at the 2016 ASCO Annual Meeting.

Cancer Research News
Jul 28 2016 · 11mins
Episode artwork

2015 ASCO Annual Meeting Research Round Up – Kidney Cancer, with Brian Rini, MD

Play
Read more

In this podcast, Dr. Brian Rini discusses some of the research on kidney cancer presented at ASCO’s 2015 Annual Meeting.

Cancer Research News
Jul 14 2015 · 14mins
Episode artwork

Just Diagnosed with Kidney Cancer--Now What? with Charles Ryan, MD and Brian Rini, MD

Play
Read more

This podcast is part of a series for patients who have just been diagnosed with a specific genitourinary, or GU cancer. In this series, Dr. Charles Ryan, a medical oncologist and associate professor who specializes in the genitourinary tract at the UCSF Helen Diller Family Comprehensive Cancer Center, speaks with experts on specific GU cancers to shed light on what happens after an initial diagnosis. 

Today’s guest is Dr. Brian Rini, an associate professor of medicine and a staff member in the Department of Solid Tumor Oncology at the Cleveland Clinic Lerner College of Medicine of Case Western Reserve University. Dr. Ryan and Dr. Rini discuss the decisions that doctors make when a patient is diagnosed with kidney cancer, including some of the factors that go into recommending certain treatment options.

Cancer Basics
Apr 14 2015 · 35mins
Episode artwork

2013 ASCO Annual Meeting Research Round Up - Kidney Cancer, with Brian Rini, MD

Play
Read more

In this podcast, we discuss some of the research on kidney cancer presented at ASCO’s 2013 Annual Meeting.

Cancer Research News
Aug 12 2013 · 11mins